Home › Research › Topics › costs
costs
265 studies tagged costs, dated 1989-11-10 to 2026-10-28. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- The Contribution of Routinely Collected Clinical Data to Dementia Identification in Primary Care: A Cross-Sectional Study 2026-10-28
- Racial Differences and Temporal Trends in Parkinson’s and Alzheimer’s Disease-Related 2026-10-24
- Prognostic heterogeneity within cognitive stages: a nationwide cohort study of everyday functional difficulties and mortality in 202,508 older adults 2026-10-23
Studies
265 studies carry this tag.
Date range
1989 to 2026
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 38
- Journal of the American Geriatrics Society 21
- medRxiv 19
- Journal of Alzheimer's disease : JAD 15
- Research Square 15
104 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
67/100
Deintensification of treatment regimens occurred in less than one-half of potentially overtreated Veterans and was more strongly associated with low HbA1c values and use of medications with high risk for hypoglycemia, rather than other resident characteristics.
-
A cognitive symptom measure identified in discharge notes facilitated stratification of risk for dementia up to 8 years before diagnosis.
-
Patients had a mean age of 70.4 (±6.6) years and 97.8% were men.
-
KmL identified 2 distinct Dependence Scale clusters: (A) high initial dependence, faster decline, and (B) low initial dependence, slower decline.
-
As Americans increase life expectancies, one disease that has captured federal attention is Alzheimer's disease.
-
Overall, the quantity and quality of available evidence to inform best practices in recruitment, retention, and inclusion of underrepresented populations in ADRD research are low.
-
The eRADAR tool uses existing EHR data to detect patients with good accuracy who may have unrecognized dementia.
-
The costs of AD were estimated to be from around 91 billion RMB in 2010 to 332 billion in 2050.
-
43/100
Participants indicated skepticism regarding the use of precision medicine in their communities.
-
Ascertainment of etiologic dementia subtype may inform hereditary risk and facilitate financial and care planning.
-
55/100
Five phenotypes were identified: (1) comorbid ischemic heart disease with hospitalization and skilled nursing facility use (22% of the HN sample), (2) comorbid ischemic heart disease with home care use (23%), (3) home care use (12%), (4) high comorbidity with hospitalization (32%), and (5) Alzheimer's disease/related dementias with functional dependency and nursing home use (11%).
-
Dementia diagnoses were a significant predictor of 30-day ED revisits.
-
Despite the growth in Medicare managed care enrollment, only 9 papers report the costs of care for individuals with ADRD within these plans, and only 1 study reports data less than 10 years old.
-
This study found that 40% of deceased beneficiaries have Alzheimer disease or unspecified dementia diagnoses in their claims history.
-
3,001,987 Medicare beneficiaries were identified, of which 8.2% had a dementia diagnosis.
-
The prevalence of low vision in the Medicare population was 994/100,000 and increased significantly with age, Black (1,854/100,000) or Hispanic (2,862/100,000) race/ethnicity, female gender (1,181/100,000), and Medicaid eligibility (2,975/100,000).
-
Dementia's five-year incremental cost to the traditional Medicare program is approximately $15 700 per patient, nearly half of which is incurred in the first year after diagnosis.
-
Program participants (n = 382 men, n = 701 women; mean [SD] age, 82.10 [7.90] years; age range 54-101 years) were less likely to be admitted to a long-term care facility (hazard ratio, 0.60; 95% CI, 0.59-0.61) than those not participating in the dementia care program (n = 759 men, n = 1407 women; mean [SD] age, 82.42 [8.50] years; age range, 34-103 years).
-
The results of the simulations show that by prolonging the length of a person's 'stay' in the Mild, Moderate, or Severe stage, the total cost of care for all persons with AD will increase by 2080.
-
Database linkage to Medicare claims records is an efficient and reasonably accurate tool to identify dementia cases in a population-based cohort.
-
43/100
We examined how methods used for identifying dementia in administrative claims affected dementia incidence across racial/ethnic populations using a 100% sample of Medicare beneficiaries (n = 23,793,452).
-
This article describes the protocol for the Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT), a single-blind randomized pilot trial to test a personalized, pragmatic, multi-domain Alzheimer's disease (AD) risk reduction intervention in a US integrated healthcare delivery system.
-
Alzheimer's disease and related dementias (ADRDs) are a global crisis facing the aging population and society as a whole.
-
53/100
Our study confirms and extends findings from other countries, demonstrating cross-sectional associations between moderate and poor self-rated vision and dementia in England in all participants aged 50 and older and longitudinally over an 11-year period in those aged 50 to 69.
-
As indicated by Cox regression modeling, dementia risk of low-educated individuals was not significantly different between ethnic groups but was related to having an APOE e4 allele (hazard ratio [HR] 1.89), depression (HR 1.67), stroke (HR 1.60), and smoking (HR 1.32).
-
Careful consideration of model specification and the profound effects of mortality selection in the older adult population is essential when investigating the relationship between aging-related diseases such as cancer and AD.
-
Stigma negatively affects individuals with cognitive impairment and dementia.
-
Our findings may suggest potential deficiencies in ambulatory care and postdischarge care related to managing comorbidities among Medicare fee-for-service ADRD patients.
-
Dementia and fragility fractures are two conditions that pose significant morbidity and mortality to the elderly population.
-
Dementia substantially increases lifetime costs of care.
-
The European Medical Information Framework initiative supports EHR data on unprecedented number of people with dementia.
-
38/100
Care of individuals with Alzheimer's Disease and Related Dementias (ADRD) poses special challenges.
-
The concomitant decline in stroke and dementia incidence rates may depict how successful stroke prevention has targeted shared risk factors of both conditions, especially at advanced ages where such risk factors are highly prevalent.
-
This article describes the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality rates, costs of care, and the overall impact on caregivers and society.
-
The associations with vascular dementia may be one component of a broader association between autoimmune diseases and vascular damage.
-
Further, we do not know if ACP uptake is greater among those in worse health and with poorer prognoses.
-
Comorbidities in community-living older adults with dementia are common and account for a substantial proportion of health service use and costs in this population.
-
Recovery rates are low, even among those with higher levels of pre-fracture functional status, and are worse for patients who are older, cognitively impaired, and who have multiple comorbidities.
-
Algorithms developed from health administrative data are sensitive and specific for identifying older adults with AD-RD.
-
Due to the rapid increase of the number in people with dementia, social costs of dementia are also expected to rise.
-
In patients with osteoporosis and no recent fracture, falls, older age, poorer health status, comorbidities, and other potential fall risk factors were predictive of imminent risk for fracture.
-
We examine a recent dispute regarding the Centers for Medicare and Medicaid Services' (CMS) refusal to unconditionally pay for amyloid positron emission tomography (PET) imaging for Medicare beneficiaries being assessed for Alzheimer's disease.
-
Hospitalised people with cognitive impairment experience significantly greater length of stay and when discharged to their usual residence are more likely to be readmitted to hospital within 28 days compared with those without cognitive impairment.
-
Although persons with dementia are frequently hospitalized, relatively little is known about the health profile, patterns of health care use, and mortality rates for patients with dementia who access care in the emergency department (ED).
-
This study provides evidence that the increase in dementia-free life years went together with an absolute compression of life years with dementia.
-
Patients with prior AD diagnosis used substantially more medical services every year until their VD/PD diagnosis, resulting in incremental annual medical costs of approximately $9,500-$14,000.
-
Neurodegenerative disease in patients with chronic obstructive pulmonary disease (COPD) was observed.
-
Cost estimates did not differ significantly between CN and MCI.
-
Dialysis modality is associated with incident dementia in a cohort of older ESRD patients.
-
Efforts to delay onset of dementia, if successful, would likely benefit older adults of all ages.
From across this tag
10 of the 265 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- Cost-effectiveness of amyloid-targeting therapies in a memory clinic population; a simulation study
- Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
- Racial and Ethnic Differences in the Population-Attributable Fractions of Alzheimer Disease and Related Dementias
- Frequency and implications of coexistent manifestations of serious illness in older adults with dementia
- Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan
- Representativeness of Participants Eligible to Be Enrolled in Clinical Trials of Aducanumab for Alzheimer Disease Compared With Medicare Beneficiaries With Alzheimer Disease and Mild Cognitive Impairment
- Economic Burden of Alzheimer's Disease Dementia in Japan
- Assessments of the Value of New Interventions Should Include Health Equity Impact
- Prevalence of dementia and cognitive impairment among older adults with hip fractures
- Successful Discharge to Community Gap of FFS Medicare Beneficiaries With and Without ADRD Narrowed